Here’s what we know about booster shots for Moderna’s and J&J’s COVID-19 vaccines
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
INFORMS has awarded Microsoft (NASDAQ: MSFT) its 2026 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for reengineering how global cloud infrastructure is planned and delivered, applying advanced analytics and AI to orchestrate complex fulfillment decisions across its rapidly expanding data center network.
INFORMS has awarded the 2026 UPS George D. Smith Prize to the Georgia Institute of Technology (Georgia Tech). The award recognizes excellence in preparing students to become practitioners of O.R. and analytics.
In the rush to adopt artificial intelligence, many employers are now requiring that employees use AI tools. As you’re using AI, be intentional and selective. It’s critical that you know yourself. Research published in Management Science found that AI is most valuable for people who understand their own abilities and limitations. Assess yourself, so you can factor this into your process for incorporating AI into your work.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
Step into one of Maryum Al-Hammami’s Southern California toy stores called The Game Chest, and you'll find the experience is as important as a purchase.
The supply chain disruption is shorthand for problems from factory closures to workers who are not working anymore.
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).
Commercial brokers have always crunched data to make sure an investment makes financial sense. But high-tech analytics can take that analysis to a new level.

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine